DV Biomed Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	116.29	213.98	226.25	456.83	557.62	533.61
Short-Term Investments	75.39	100.54	45.22	124	38.5	-
Trading Asset Securities	125.56	65.91	4.38	4.34	4.74	4.68
Cash & Short-Term Investments	317.24	380.42	275.85	585.17	600.86	538.29
Cash Growth	15.53%	37.91%	-52.86%	-2.61%	11.62%	-10.96%
Accounts Receivable	33.51	55.05	80.19	239.56	292.18	256.55
Other Receivables	0.47	7	5.88	17	14.3	12.85
Receivables	33.98	62.06	86.07	256.55	306.49	269.39
Inventory	97.63	72.08	66.73	133.9	132.07	111.63
Prepaid Expenses	38.87	41.73	15.36	30.09	38.47	34.62
Other Current Assets	0.04	0.22	0.57	0.06	-	0.03
Total Current Assets	487.76	556.5	444.57	1,006	1,078	953.96
Property, Plant & Equipment	59.67	47.53	55.31	585.81	415.6	447.98
Long-Term Investments	30.04	30.04	-	182.43	178.23	209.32
Other Intangible Assets	8.27	4.12	0.9	3.43	5.32	4.64
Long-Term Accounts Receivable	-	67.51	-	-	-	-
Long-Term Deferred Tax Assets	69.37	65.57	66.22	77.03	64.33	66.98
Other Long-Term Assets	7.63	5.94	28.29	198.78	116.22	144.6
Total Assets	662.75	777.22	595.29	2,053	1,858	1,827
Accounts Payable	54.87	32.85	28	110.25	115.37	96.35
Accrued Expenses	45.59	41.27	68.78	81.54	83.78	74.05
Current Portion of Leases	13.54	32.11	3.75	80.66	62.32	61.77
Current Income Taxes Payable	0.22	4.7	-	41.52	43.05	28.07
Current Unearned Revenue	7.44	3.29	1.28	116.21	115.27	95.5
Other Current Liabilities	23.7	24.4	13.05	50.58	69.28	55.27
Total Current Liabilities	145.35	138.62	114.87	480.77	489.07	411.01
Long-Term Leases	34.5	99.63	-	385.86	161.77	188.16
Long-Term Deferred Tax Liabilities	0.03	0.94	0.12	6.92	-	-
Other Long-Term Liabilities	3.82	3.82	3.82	34.6	27.85	24.54
Total Liabilities	183.7	243.01	118.81	908.14	678.68	623.71
Common Stock	206.35	208.61	604.47	614.47	602.61	602.61
Additional Paid-In Capital	7.03	7.11	190.28	211.51	179.37	182.49
Retained Earnings	247.81	345.74	307.27	431.35	468.6	489.96
Treasury Stock	-	-14.55	-42.16	-100.69	-58.53	-58.53
Comprehensive Income & Other	17.86	-12.7	-13.09	-11.53	-13.16	-12.76
Total Common Equity	479.05	534.21	1,047	1,145	1,179	1,204
Minority Interest	-	-	-570.29	-	-	-
Shareholders' Equity	479.05	534.21	476.48	1,145	1,179	1,204
Total Liabilities & Equity	662.75	777.22	595.29	2,053	1,858	1,827
Total Debt	48.04	131.74	3.75	466.52	224.09	249.93
Net Cash (Debt)	269.2	248.69	272.1	118.65	376.77	288.37
Net Cash Growth	11.14%	-8.60%	129.34%	-68.51%	30.65%	4.04%
Net Cash Per Share	11.05	10.20	11.14	4.85	15.29	11.60
Filing Date Shares Outstanding	24.35	24.35	24.35	24.35	24.62	24.62
Total Common Shares Outstanding	24.35	24.35	24.35	24.35	24.62	24.62
Working Capital	342.42	417.88	329.7	525.01	588.81	542.95
Book Value Per Share	19.67	21.94	42.99	47.03	47.88	48.89
Tangible Book Value	470.78	530.08	1,046	1,142	1,174	1,199
Tangible Book Value Per Share	19.33	21.77	42.95	46.89	47.66	48.70
Buildings	-	-	55.62	81.98	80.66	80.68
Machinery	27.72	17.83	17.75	332.79	75.96	60.24
Construction In Progress	-	-	-	23	15.29	16.08
Leasehold Improvements	22.52	22.52	21.6	-	225.83	217.3

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.